Biotech China 2014

View Profile

Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors
1. 2009 Technological Advancements in Radiation Oncology. Seminars in Radiation Oncology 19(3): 179-186, 2009.
2. 2009 Molecular Advances of Brain Tumors in Radiation Oncology Seminars in Radiation Oncology 19(3):171-178, 2009
3. 2009 Molecular Profiling in Glioblastoma: Prelude to Personalized Treatment Curr Oncol Rep. 11(1):53-61, 2009
4. 2009 Prognostic value of surviving in locally advanced prostate cancer: a Study based on RTOG 8610. Int J. Radiat Oncol Biol Phys. 73(4):1033-1042, 2009.
5. 2009 In vitro and in vivo radiosensitization of glioblastoma cells by the poly (ADP-ribose) polymerase inhibitor E7016 Clin Cancer Res 15(2):607-612
6. 2008 Overcoming therapeutic resistance in malignant gliomas: current practices and future directions Cancer Treat Res. 2008; 139: 173-189
7. 2008 The added value of concurrently-administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma. J. Neurooncol. 2008 May;88(1):43-50
8. 2008 Detection of EGFRvIII in routinely processed GBM clinical samples Clin Ca Res 2008; 14(2): 488-493
9. 2008 Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole brain radiotherapy with or without thalidomide on RTOG 0118 Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):71-8.
10. 2008 Phase III Study of Conventional Radiation Therapy Plus Thalidomide versus Conventional Radiation Therapy for Multiple Brain Metastasis Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):79-86
11. 2008 Novel Radiation Enhancing Agents in Malignant Gliomas Radiosurgery 2008
12. 2008 The prognostic value of nestin expression in newly diagnosed glioblastoma: report from the RTOG Radiat Oncol 3(32), 2008
13. 2008 Overcoming therapeutic resistance in malignant gliomas: current practices and future directions Cancer Treat Res. 139:173-189, 2008.
14. 2008 Biomarkers of clinical responsiveness in brain tumor patients: progress and potential Mol Diagn Ther 12(4): 199-208, 2008.
15. 2007 Chemoradiotherapy in malignant glioma: standard of care and future directions J. Clin Oncol 2007; 25(26): 4127-4136
16. 2007 The prognostic value of p16 in locally-advanced prostate cancer: a report from RTOG 9202 J. Clin Oncol 2007; 25(21): 3082-3089
17. 2007 Molecular and genetic profiling in human gliomas. Disc Med 7(38): 75-81, 2007
18. 2007 The Impact of Molecular Profiling on Clinical Trial Design in Glioblastoma Curr Oncol Rep. 2007 Jan;9(1):71-9.
19. 2006 Advancement of CNS Targeted Agents Combined with Radiation. Radiation Oncology Advances 2006
20. 2006 A phase II study of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023. Int J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1422-8
21. 2006 A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA as a mitogen in glioblastoma. Cancer Res . 2006 Nov 15;66(22):10815-23
22. 2006 Interpretation of molecular marker data in the modern era. Int J. Radiat. Oncol. Biol. Phys. 2006; 66(1):1-2
23. 2006 A phase II study of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023 Int J of Radiat Oncol Biol Phys 2006; 65(5):1422-1428.
24. 2006 A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA as a mitogen in glioblastoma Cancer Res 2006; 66(22): 10815-10823
25. 2006 Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplasticglioma? Crit Rev Oncol Hematol. 2006 Nov;60(2):99-111.
26. 2006 Radiation Enhancing Agents for Tumors of the Central Nervous System Semin Radiat Oncol. 2006 Jan;16(1):29-37
27. 2006 Predictive and prognostic markers in prostate cancer Curr Cancer Ther Rev. 2006 Nov;7(6):490-504
28. 2006 Radiation-induced RhoA activation increases cellular invasion and motility of glioblastoma cells via IGFR/AKT-dependent signaling J. Neurooncol, 2006 Feb;76(3):227-37.
29. 2006 Temozolomide-mediated radiation enhancement in gliomas: a report on underlying mechanisms Clin Ca Res 2006; 12(15):4738-4746
30. 2005 Immunohistochemically-Determined Total Epidermal Growth Factor Receptor (EGFR) Levels are not of Prognostic Value in Newly-Diagnosed Glioblastoma Multiforme (GBM): A Report from the Radiation Therapy Oncology Group (RTOG). Int J. Rad Oncol Biol Phys. 2005 Jun 1; 62(2):318-327
31. 2005 Survivin mediates resistance to antiandrogen therapy in prostate cancer Oncogene 2005 Apr 7; 24(15): 2474-2482
32. 2005 Results of Whole- Brain Radiation as Salvage of Methotrexate Failure in Patients with Primary Central Nervous System Lymphoma. J Clin Oncol 2005 Mar 1; 23(7):1507-1513.
33. 2005 Adenovirus-mediated Inhibition of Survivin Expression Sensitizes Human Prostate Cancer Cells to Paclitaxel In Vitro and In Vivo. Prostate 2005 Aug 1;64(3):293-302
34. 2005 Cellular and genetic changes in malignant gliomas following irradiation in patients requiring early reresection of progressive tumor J. Neurooncol 2005 Sept;74(2):151-4
35. 2005 Expression of the Epidermal Growth Factor Receptor (EGFR) is Associated with Improved Outcome in Muscle-Invading Bladder Cancer Int J. Rad Oncol Biol Phys. 2005 Jun 1; 62(2): 309-317.
36. 2005 Prostate Cancer Biomarkers. Oncogenomics. Humana Press, 2005
37. 2005 Brachytherapy for CNS Neoplasms Brachytherapy. Lippincott, 2005.
38. 2004 Survivin Enhances Radiation Resistance in Primary Human Glioblastoma Cells via Caspase-Independent Mechanisms. Oncogene. 2004 Sep 30;23(45):7494-506
39. 2004 The contribution of Epidermal Growth Factor Receptor (EGFR) signaling pathway to radioresistance in human gliomas: A review of preclinical and correlative clinical data 1. Int J Rad Onc Biol Phys 2004; 58(3): 927-931.
40. 2004 Molecular and genetic markers in gliomas of prognostic value Cancer of the Central Nervous System (Second Edition: editors: Black, P.McL. and Loeffler, J.S.) Lippincott Williams and Wilkins, 2004
41. 2004 The Prognostic Significance of Phosphatidylinositol 3-Kinase Pathway Activation in Human Gliomas J Clin Oncol 2004 May 15;22(10):1926-33
42. 2004 The combination of adenoviral HSV TK gene therapy and radiation is effective in athymic mouse glioblastoma xenografts without increasing toxic side effects J Neurooncol. 2004 Mar-Apr;67(1-2):177-88
43. 2003 Loss of p16 expression is of prognostic significance in locally advanced prostate cancer: An analysis from RTOG 86-10. J Clin Oncol 2003
44. 2003 Molecular and prognostic factors of prostate cancer. World J. Urol. 2003; 21(4):265-274
45. 2002 Quantitatively-determined urviving expression levels are of prognostic value in human gliomas J Clin Oncol. 2002; 20(4):1063-1068
46. 2002 The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner Cancer Res. 2002; 62(15):4307-4315
47. 2002 Insulin-like growth factor receptor I (IGFRI) mediates resistance to anti-epidermal growth factor receptor (EGFR) therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling Cancer Res. 2002; 62(1):200-207.
48. 2001 Prognostic and pathologic significance of protein expression profiling in human gliomas Clinical Cancer Research 2001; 7:2387-2395
49. 2001 Radiation Research Program, Radiation Oncology Sciences Program, NCI-HIH Int J Rad Onc Biol Phys 2001; 49(5): 1505-1516.
50. 2001 Translational Research Program Int J Radiat Oncol Biol Phys 2001; 51(3 suppl 2): 75-87.
51. 2000 Thymosin b15 predicts for distant failure for patients with clinically localized prostate cancer Urology 2000; 55(5):635-638.
52. 2000 Case records of the Massachusetts General Hospital. Case 18-2000. A 45-year-old woman with a thoracic mass and Pancoast’s syndrome. 1. New England Journal of Medicine 2000; 342(24): 1814-1821.
53. 1999 Ir-192 brachytherapy in the management of primary bile duct tumors. 1. Applied Radiology 1999; 28(4): 22-26.
54. 1999 Long-term follow-up of patients with rectal cancer managed by local excision with and without adjuvant therapy. Annals of Surgery 1999; 230(1): 49-54.
55. 1999 Radiation therapy in the management of giant cell tumor of bone J. of Bone and Joint Surgery 1999; 81A: 1566-1573.
56. 1998 Loss of heterozygosity at chromosome 11q23 in SCC of the head and neck is associated with recurrent disease Clinical Cancer Research 1998; 4(11):2787-2793.
57. 1997 The effect of intravenous erythromycin on solid meal gastric emptying in patients with chronic symptomatic post-vagotomy-antrectomy gastroparesis Aliment. Pharmacol. Ther. 1997; 11(2):381-385
58. 1996 Cosegregation of familial pseudoobstruction and presence of digital arches in a large multigenerational pedigree Digestive Diseases and Sciences 1996; 41(7):1429-1433

4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.